Table 2.
Exacerbations | Intermittent | Mild | Moderate | Severe |
---|---|---|---|---|
Symptoms | > 2 d/wk | > 2d/wk but < 1/d | Daily | > 1 daily |
Nighttime awakenings | < 2×/m | > 2×/m | > 1/wk | Nightly |
Use of short-acting beta-agonists | < 3 d/wk | ≥ 3 d/wk | Daily | Several times daily |
Interference with activity | None | Minor limitation | Some limitation | Extremely limited |
FEV1 | > 80% predicted | > 80% predicted | 60%–80% predicted | < 60% predicted |
FEV1/FVC ratio | Normal | Normal | Decreased | Decreased |
Risk | < 2/y | ≥ 2 Exacerbations/y requiring oral or parenteral steroids |
Abbreviations: FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity.